Press release
July 22, 2026
Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call
Zevra Therapeutics, Inc. (ZVRA)
BOSTON, Mass., July 22, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced it will report corporate and financial results for the